Decreased levels of HDL have been observed in the peripheral blood of CLL patients compared to aged matched healthy controls [33], which may be due to the overexpression of SR-B1 on CLL cells [34], leading to an increase in the sequestration of HDL into tumour cells (Figure 2). The gene discussed is SCARB1; the disease is B-cell chronic lymphocytic leukemia.